The BIM deletion polymorphism and its clinical implication in patients with EGFR-mutant non-small-cell lung cancer treated with EGFR tyrosine kinase inhibitors

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The BIM deletion polymorphism and its clinical implication in patients with EGFR-mutant non-small-cell lung cancer treated with EGFR tyrosine kinase inhibitors'. Together they form a unique fingerprint.
Sort by

Biochemistry, Genetics and Molecular Biology